EUROPEAN MARKETS FOR PROSTHETIC VASCULAR GRAFTS

182 Pages | 39 Exhibits | 2013 Analysis | Forecasts Through 2017 Product Family: Market Reports




OVERVIEW:
The number of patients in Europe receiving prosthetic grafts for aneurysm repair, coronary and peripheral vessel reconstruction, and hemodialysis access is expected to increase over the forecast period covered by this report due to the prevalence of both diabetes and cardiovascular disease in the region. In 2012, European sales of prosthetic vascular grafts totaled approximately $865 million; of this, endovascular stent-grafts for aortic aneurysm repair accounted for nearly 87% of sales, followed by peripheral vascular grafts with 10%, hemodialysis access grafts with 3%, and small-diameter CABG grafts with less than 1%. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 8.1%, reaching nearly $1.3 billion in the year 2017. Growth will be driven by technological advancements, population demographics, the growing prevalence of diabetes, and an increase in the number of interventional vascular surgeons in Europe.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European prosthetic vascular grafts market. Major topics covered by this report include an overview of selected cardiovascular diseases and disorders (e.g., aneurysm, coronary heart disease, diabetes, hypertension, and stroke); cardiovascular disease management options; and a discussion of products, competitors, and forecast markets for prosthetic vascular graft segments including endovascular stent-grafts for aortic aneurysm repair, hemodialysis access grafts, peripheral vascular grafts, and small-diameter CABG grafts.

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Prosthetic Vascular Grafts
	a. Applications
	b. Product Categories
	c. Hemodialysis Access Grafts
	d. Endovascular Stent-Grafts for Aortic Aneurysm Repair
	e. Peripheral Vascular Grafts
	f. Small-Diameter Coronary Artery Bypass Grafts
	g. Combined Market Analysis

Exhibit ES-1: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017
Exhibit ES-2: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017
Exhibit ES-3: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017
Exhibit ES-4: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017
Exhibit ES-5: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

1.1 Cardiovascular Diseases/Disorders
	1.1.1 Coronary Heart Disease
		1.1.1.1 Atherosclerosis
			1.1.1.1.1 Description
			1.1.1.1.2 Statistics
		1.1.1.2 Angina Pectoris
			1.1.1.2.1 Description
			1.1.1.2.2 Statistics
		1.1.1.3 Myocardial Infarction
			1.1.1.3.1 Description
			1.1.1.3.2 Statistics
	1.1.2 Hypertension
		1.1.2.1 Description
		1.1.2.2 Statistics
	1.1.3 Aneurysm
		1.1.3.1 Description
		1.1.3.2 Statistics
	1.1.4 Stroke
		1.1.4.1 Description
		1.1.4.2 Statistics
	1.1.5 Diabetes
		1.1.5.1 Description
		1.1.5.2 Statistics
1.2 Cardiovascular Disease Management Options
	1.2.1 Medical Management
		1.2.1.1 Lifestyle Changes
			1.2.1.1.1 Dietary Modification
			1.2.1.1.2 Smoking Cessation
		1.2.1.2 Pharmaceuticals
			1.2.1.2.1 Anticoagulants and Antiplatelet Drugs
			1.2.1.2.2 Lipid-Lowering Drugs
			1.2.1.2.3 Antihypertensive Drugs
			1.2.1.2.4 Nitroglycerin Preparations
	1.2.2 Intracoronary Heart Disease Diagnosis
		1.2.2.1 Coronary Angiography
			1.2.2.1.1 Description
			1.2.2.1.2 Statistics
	1.2.3 Coronary Artery Disease Treatment
		1.2.3.1 Coronary Artery Bypass Graft Surgery
			1.2.3.1.1 Less Invasive Coronary Artery Bypass Graft Techniques
		1.2.3.2 Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting
		1.2.3.3 Peripheral Percutaneous Revascularization Techniques
			1.2.3.3.1 Percutaneous Transluminal Angioplasty and Peripheral Stenting
			1.2.3.3.2 Peripheral Atherectomy
			1.2.3.3.3 Peripheral Femoropopliteal Stenting

Exhibit 1-1: Number of Deaths due to Cardiovascular Diseases/Disorders, by Gender
Exhibit 1-2: 2008, Prevalence of Hypercholesterolemia, by Gender
Exhibit 1-3: Standard Angina Pectoris Classification
Exhibit 1-4: 30-Day Case Fatality Rates Following Hospital Admission for Acute Myocardial Infarction, Selected European Countries
Exhibit 1-5: 2008, Prevalence of Hypertension, by Gender
Exhibit 1-6: Stroke, Hospital Discharge Rates, 2000 and 2009
Exhibit 1-7: 2008, Prevalence of Elevated Blood Glucose, by Gender
Exhibit 1-8: 2007, Daily Per-Person Consumption of Fats, Fruits, and Vegetables
Exhibit 1-9: Tobacco Smoking Rate, by Gender
Exhibit 1-10: 2006/2007, Medication at Discharge for Patients with Coronary Heart Disease, Selected European Countries
Exhibit 1-11: 2007, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, Selected European Countries
Exhibit 1-12: 2010, Coronary Artery Bypass Graft Surgery, Selected European Countries, by Type
Exhibit 1-13: 2010, Percutaneous Coronary Intervention/Stenting Procedures, Selected European Countries, by Type
Exhibit 1-14: 2010, Peripheral Vascular Disease Treatment Procedures, Selected European Countries, by Type

2. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET

2.1 Prosthetic Vascular Grafting Applications
	2.1.1 Aneurysm
	2.1.2 Kidney Failure
	2.1.3 Vascular Occlusion
2.2 Prosthetic Vascular Graft Categorization
	2.2.1 Categorization by Graft Diameter
		2.2.1.1 Large-Diameter Grafts
		2.2.1.2 Medium-Diameter Grafts
		2.2.1.3 Small-Diameter Grafts
	2.2.2 Categorization by Graft Material
		2.2.2.1 Polyester
		2.2.2.2 Polytetrafluoroethylene
		2.2.2.3 Polyurethane
		2.2.2.4 Biological
			2.2.2.4.1 Human Saphenous and Umbilical Veins
			2.2.2.4.2 Tissue-Engineered Materials
	2.2.3 Endovascular Stent-Grafts
		2.2.3.1 Performance Requirements
		2.2.3.2 Configurations
		2.2.3.3 Endovascular Stent-Graft-Related Complications
2.3 Prosthetic Vascular Grafts Market
	2.3.1 Market Drivers and Limiters
	2.3.2 Hemodialysis Access Grafts
		2.3.2.1 Market Forecast
		2.3.2.2 Competitive Analysis
	2.3.3 Endovascular Stent-Graft Systems for Aortic Aneurysm Repair
		2.3.3.1 Market Forecast
		2.3.3.2 Competitive Analysis
	2.3.4 Peripheral Vascular Grafts
		2.3.4.1 Market Forecast
		2.3.4.2 Competitive Analysis
	2.3.5 Small-Diameter Coronary Artery Bypass Grafts
		2.3.5.1 Market Forecast
		2.3.5.2 Competitive Analysis
	2.3.6 Combined Market Forecast

Exhibit 2-1: Indications for the Use of Prosthetic Vascular Grafts
Exhibit 2-2: Interventions for the Treatment of Peripheral Vascular Occlusions
Exhibit 2-3: Design Criteria for Synthetic Vascular Grafts
Exhibit 2-4: Applications for Prosthetic Vascular Grafts, by Diameter
Exhibit 2-5: 2013, Selected Polyester Vascular Grafts
Exhibit 2-6: 2013, Selected Polytetrafluoroethylene Vascular Grafts
Exhibit 2-7: 2013, Selected Polyurethane Vascular Grafts
Exhibit 2-8: Design Specifications for Endovascular Stent-Graft Systems
Exhibit 2-9: Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair
Exhibit 2-10: 2013, Selected Endovascular Stent-Grafts for Aortic Aneurysm Repair
Exhibit 2-11: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017
Exhibit 2-12: 2012, Europe, Hemodialysis Access Grafts Market, Share by Supplier
Exhibit 2-13: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017
Exhibit 2-14: 2012, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier
Exhibit 2-15: 2012, Europe, Endovascular Thoracic Aortic Aneurysm Stent-Grafts Market, Share by Supplier
Exhibit 2-16: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017
Exhibit 2-17: 2012, Europe, Peripheral Vascular Grafts Market, Share by Supplier
Exhibit 2-18: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017
Exhibit 2-19: 2012, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier
Exhibit 2-20: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

3. COMPANY PROFILES

3.1 Atrium Medical Corporation/Getinge Group AB
3.2 C.R. Bard, Inc.
3.3 Cook Group, Inc.
3.4 W.L. Gore & Associates, Inc.
3.5 Maquet Vascular Interventions/Getinge Group AB
3.6 Medtronic, Inc.
3.7 Vascutek LTD/Terumo Corporation

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. 3M Health Care/3M
  2. Abbott Laboratories
  3. Actavis, Inc.
  4. Akrimax Pharmaceuticals LLC
  5. Arbor Pharmaceuticals, Inc
  6. AstraZeneca PLC
  7. Atrium Medical Corporation/Getinge Group AB
  8. Bard Peripheral Vascular/C.R. Bard, Inc.
  9. C.R. Bard, Inc.
  10. Bayer AG
  11. Bolton Medical, Inc./Werfen Life Group
  12. B. Braun Melsungen AG
  13. Bristol-Myers Squibb Company
  14. Cook Group, Inc.
  15. Cook Medical/Cook Group, Inc.
  16. Correvio International Sarl
  17. Endologix, Inc.
  18. EKR Therapeutics, Inc./Cornerstone Therapeutics, Inc.
  19. Fougera Pharmaceuticals, Inc./Sandoz AG/Novartis AG
  20. GlaxoSmithKline PLC
  21. W.L Gore & Associates, Inc.
  22. Janssen Biotech, Inc./Johnson & Johnson
  23. Johnson & Johnson
  24. Jotec GmbH
  25. Kowa Pharmaceuticals Europe, Inc./KOWA Company LTD
  26. LeMaitre Vascular, Inc.
  27. Eli Lilly and Company
  28. Maquet Vascular Interventions/Getinge Group AB
  29. Medicure, Inc.
  30. Medtronic, Inc.
  31. Merck & Co., Inc.
  32. Millennium Pharmaceuticals, Inc./Takeda Pharmaceutical Company LTD
  33. Novartis AG
  34. Pfizer, Inc.
  35. Sanofi SA
  36. Schwarz Pharma/UCB SA
  37. Shionogi, Inc.
  38. TriVascular, Inc.
  39. Valeant Pharmaceuticals International, Inc.
  40. Vascutek LTD/Terumo Corporation
  41. XOMA LTD
Contact Us

Need help finding medtech research? Let us help you!